Mixed trend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Oct 25 · inside the Ichimoku cloud · RSI 16 (oversold) · MACD above its signal · at its 52-week high
No member of Congress has disclosed a THCBF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for THCBF.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2024 | -8.0 | -16.2 | -4.8 | 22.3 | -24.9 | -69.3 | 409.7 | 6.3 | 45.8 | -95.9 | 0.0 | 0.0 | −93.3% |
| 2023 | 28.9 | 95.1 | -11.1 | -8.5 | 0.3 | -32.1 | -8.2 | -17.3 | -25.4 | -4.0 | 38.9 | -25.0 | −21.1% |
| 2022 | -4.8 | 5.0 | 10.0 | -26.9 | -8.0 | -3.6 | -11.8 | 0.4 | -20.6 | -20.3 | -14.9 | -5.0 | −67.7% |
| 2021 | 50.3 | 15.6 | 6.3 | -16.5 | -11.6 | 1.4 | -20.4 | -13.1 | 0.3 | 8.7 | -3.0 | -21.6 | −20.8% |
| 2020 | -8.7 | -11.9 | -21.2 | -0.4 | 27.3 | 65.3 | -5.5 | -18.9 | -16.1 | -30.4 | 10.3 | -5.4 | −37.9% |
| 2019 | 30.3 | 6.8 | -25.4 | -20.4 | 5.5 | -27.9 | -6.9 | -10.8 | -7.4 | -14.1 | 10.0 | 8.4 | −50.4% |
| 2018 | 98.2 | -32.5 | 17.3 | -19.4 | -13.6 | 0.5 | -6.6 | -1.3 | -18.8 | -29.1 | -24.1 | -30.1 | −69.0% |
| 2017 | -22.0 | 15.1 | -14.8 | -19.7 | -15.2 | -18.5 | 1.6 | 33.2 | 49.5 | -5.8 | -0.9 | 31.9 | +5.7% |
| 2016 | 11.3 | 32.9 | -14.3 | -5.2 | -3.9 | 6.1 | -0.6 | 193.2 | 135.2 | 18.0 | 15.9 | -9.9 | +935.2% |
| 2015 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -18.0 | 10.0 | 36.4 | 2.7 | -7.8 | +16.4% |
| 2014 | 0.0 | 0.0 | 4023.8 | -4.2 | -26.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +2804.8% |
| 2013 | -38.1 | 0.0 | 0.0 | 0.0 | -23.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -79.0 | −90.0% |
| 2012 | 17.3 | -18.6 | 5.2 | -42.4 | -27.8 | 0.0 | -64.3 | 106.7 | 0.0 | 0.0 | -32.3 | 0.0 | −79.1% |
| 2011 | -3.2 | 7.4 | -8.0 | 12.7 | -14.1 | 23.2 | 3.8 | -26.4 | -29.0 | -19.1 | -5.3 | -50.9 | −76.7% |
| 2010 | 10.8 | -4.0 | 0.0 | 16.5 | -60.5 | 0.0 | 88.6 | 47.1 | 12.9 | 72.3 | +164.1% |
None of the 29 investors followed here reported a position in THCBF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No analyst coverage for this instrument.
THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under the Always Hi brand name; and transport solution for young live plants under the Cloneshipper brand name. The company was founded in 2012 and is based in Kelowna, Canada.
No recent headlines.